Stay updated on Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1, which appears to be an internal site version update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes observed to study details or instructions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded a glossary display option and updated metadata labels to show Last Update Submitted that Met QC Criteria and Revision: v3.4.0. Removed the older label Last Update Submitted that met QC Criteria, the No FEAR Act data wording, and the older Revision: v3.3.4.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check82 days agoChange DetectedLocations section now lists trial sites across Alabama, Colorado, Florida, Georgia, Michigan, Missouri, Nebraska, New Jersey, Ohio, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, and Virginia. The page shows a new Revision: v3.3.3 tag.SummaryDifference2%

Stay in the know with updates to Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.